6400 RESULTS
Sort By:
Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function Keystone Symposia Meeting,
An APP variant reported to stave off Alzheimer’s disease occurs in about one in 6,500 Americans.
Neuroinflammation Field Grapples With Complexity at Keystone Symposia Nature Versus Nurture: What Gives Microglia Their Identity? Microglia in Disease: Innocent Bystanders, or Agents of Destruction? United in Confusion: TREM2 Puzzles Researchers in Taos C
A TMEM106B variant widely influences the formation of TDP-43 inclusions, even in people without noticeable signs of neurodegeneration.
Researchers strongly agree that brain banks are indispensable for important discoveries in neurodegenerative disease, but funding shortfalls now threaten to stall the pace of progress.
Worldwide, brain banks are combining their holdings into large databases in an effort to better support neurodegenerative disease research.
Did you know? The NACC’s brain tissue comes with extensive clinical and cognitive data, enabling in-depth studies.
Researchers at a recent Keystone symposium compared the properties of microglia with those of other macrophages in the body. The cells acquire their unique personalities through both their origins and their present environment.
Researchers at Keystone attempted to distinguish microglia from other macrophages in the body, both in form and function, and monitor the way each behaves during disease.
Researchers sequenced the exomes of nearly 3,000 people with ALS to identify the new gene.
At the first NIH summit since the National Plan to Address Alzheimer’s was implemented back in 2012, scientists discussed progress made and put forth a new set of goals.
At an NIH conference in Washington, D.C., experts from beyond Alzheimer’s research discussed ways to beef up data collection and patient participation.
Alzheimer’s Disease Research Summit 2015: Three Years In Alzheimer's Disease Research Summit 2015: Expanding the Horizon Research Summit 2015 Recommendations Released The National Institutes of Health hosted a meeting earlier this month as leaders in
At Keystone, scientists reported that TREM2 may promote the survival of cells surrounding plaques, but where these cells come from and what they do is still up for grabs.
Hollywood has discovered the narrative power of neurodegenerative diseases.
